Koninklijke Philips N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
15 dec 2008 - 12:22
Statutaire naam
Koninklijke Philips N.V.
Titel
Philips further expands Home Healthcare solutions with acquisition of aerosol therapy business of Medel in Italy
Bericht
• Philips also acquires, in a related transaction, strategically important manufacturing facility in Guangdong, China for nebulizer compressor systems
• Transactions further strengthen Philips Healthcare’s emerging markets footprint and solidifies global leadership position in Home Healthcare
Amsterdam, the Netherlands and Parma, Italy – Royal Philips Electronics (NYSE:PHG, AEX:PHI) today announced it has acquired the aerosol therapy business of Medel SpA in Italy. In a related transaction, Philips also acquired a manufacturing facility in Guandong, China for nebulizer compressor systems and operations in Hong Kong. Medel is a privately held Italian distributor of nebulizer compressor systems and other home healthcare products. The acquired businesses have become part of the Respiratory Drug Delivery, or RDD, business unit within Philips Home Healthcare Solutions. Financial details of this agreement were not disclosed.
Today’s announcement marks Philips’ ambition to expand its Home Healthcare Solutions business, further cementing its global leadership position in this industry, and marks its growing industrial and commercial presence in high-growth healthcare markets in emerging economies. The addition of the Guangdong facility means another significant expansion of Philips Healthcare’s industrial footprint in China following the acquisition of the country’s second-largest patient monitoring company Shenzhen Goldway Industrial in April 2008.
Philips Home Healthcare Solutions CEO Don Spence, who in November 2008 succeeded former chief executive John Miclot, said: “When Philips acquired Respironics, the company also had a leading respiratory drug delivery business. Building upon that strength and fulfilling on our ambition to expand our high-growth compressor nebulizer systems franchise, we decided to acquire the aerosol therapy business of Medel which
Gerelateerde downloads
Datum laatste update: 25 december 2025